TOWA Pharmaceutical Co Ltd 4553

Morningstar Rating
¥3,495.00 −75.00 (2.10%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4553 is trading at a LOCK|#zJdW premium.
Price
¥3,495.00
Fair Value
LOCK|^z.%ZdVl^
Uncertainty
LOCK|q@
1-Star Price
LOCK|SR.&dv?>MB>
5-Star Price
LOCK|Q!.DrLgf#
Economic Moat
LOCK|L<k
Capital Allocation
—

Trading Information

Previous Close Price
¥3,570.00
Day Range
¥3,485.00–3,555.00
52-Week Range
¥2,764.00–4,490.00
Bid/Ask
¥3,490.00 / ¥3,510.00
Shares Outstanding
49.23M
Market Cap
¥172.05B
Volume/Avg
97,600 / 117,055

Key Statistics

Price/Earnings (Normalized)
32.16
Price/Sales
0.64
Dividend Yield (Trailing)
2.29%
Dividend Yield (Forward)
2.29%
Dividend Payment Schedule
Jun, Dec
Total Yield
2.29%

Company Profile

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
5,642

Valuation

Metric
4553
Price/Earnings (Normalized)
32.16
Price/Book Value
0.96
Price/Sales
0.64
Price/Cash Flow
4.16
Price/Earnings
4553

Financial Strength

Metric
4553
Quick Ratio
1.12
Current Ratio
2.76
Interest Coverage
6.69
Quick Ratio
4553

Profitability

Metric
4553
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
4553

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|S$&tPf&&LOCK|v%c?$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|?%wvsRqjLOCK|@z<Y$46B
Haleon PLC ADR
HLN
LOCK|TnRJk<LOCK|^P$38B
Zoetis Inc Class A
ZTS
LOCK|s@?s&z<pLOCK|WNg$29B
Viatris Inc
VTRS
LOCK|NyT<LhLOCK|Pv?$20B
Elanco Animal Health Inc
ELAN
LOCK|G@LOCK|>M$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|VKbvkpLOCK|@^$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|^gjp!BLOCK|!W$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|bRTg<hLOCK|y>L@p$2B
Perrigo Co PLC
PRGO
LOCK|w!&l<#jLOCK|@>$2B

Sponsor Center